EnzBond
Enzbond utilises its proprietary, AI-driven 'Simulated Environment' technology to develop new enzymes that dramatically reduce the cost and environmental impact of drug manufacture.
- What
- Life Sciences
- When
- Nov 2016
- CEO
- Robert Simion
- Status
- Private
- Investment
- Active
- OSE Board Director
- Nick Dixon-Clegg